Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication

Neuroscience Research

Volumn 72, Issue 1, 2012, Pages 32-42

  Steelman, Andrew J ^a   Thompson, Jeffrey P ^a   Li, Jianrong ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Cuprizone model; Demyelination; Gliosis; Myelin repair; Oligodendrocytes; Remyelination

Indexed keywords

CUPRIZONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BRAIN REGION; CONTROLLED STUDY; CORPUS CALLOSUM; DEMYELINATION; ELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIOSIS; MOUSE; NEUROANATOMY; NONHUMAN; PRIORITY JOURNAL; REMYELINIZATION; WEIGHT REDUCTION;

ANIMALS; AXONS; BRAIN; CORPUS CALLOSUM; CUPRIZONE; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; GLIOSIS; MALE; MICE; MICE, INBRED C57BL; MICROGLIA; MYELIN SHEATH; NERVE TISSUE PROTEINS; OLIGODENDROGLIA; WEIGHT LOSS;

EID: 83155192141     PISSN: 01680102     EISSN: 18728111     Source Type: Journal    
DOI: 10.1016/j.neures.2011.10.002     Document Type: Article

References (45)

1. Arnett H.A., Mason J., Marino M., Suzuki K., Matsushima G.K., Ting J.P. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat. Neurosci. 2001, 4:1116-1122.
2. Bando Y., Takakusaki K., Ito S., Terayama R., Kashiwayanagi M., Yoshida S. Differential changes in axonal conduction following CNS demyelination in two mouse models. Eur. J. Neurosci. 2008, 28:1731-1742.
3. Barnett M.H., Prineas J.W. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann. Neurol. 2004, 55:458-468.
4. Binder M.D., Cate H.S., Prieto A.L., Kemper D., Butzkueven H., Gresle M.M., Cipriani T., Jokubaitis V.G., Carmeliet P., Kilpatrick T.J. Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelination. J. Neurosci. 2008, 28:5195-5206.
5. Blakemore W.F. Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice. J. Neurocytol. 1972, 1:413-426.
6. Blakemore W.F. Demyelination of the superior cerebellar peduncle in the mouse induced by cuprizone. J. Neurol. Sci. 1973, 20:63-72.
7. Breij E.C., Brink B.P., Veerhuis R., van den Berg C., Vloet R., Yan R., Dijkstra C.D., van der Valk P., Bo L. Homogeneity of active demyelinating lesions in established multiple sclerosis. Ann. Neurol. 2008, 63:16-25.
8. Carlton W.W., Kreutzberg G. Isonicotinic acid hydrazide-induced spongy degeneration of the white matter in the brains of Pekin ducks. Am. J. Pathol. 1966, 48:91-105.
9. Compston A., Coles A. Multiple sclerosis. Lancet 2008, 372:1502-1517.
10. Duncan I.D., Brower A., Kondo Y., Curlee J.F., Schultz R.D. Extensive remyelination of the CNS leads to functional recovery. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:6832-6836.
11. Franklin B.J., Paxinos G. The Mouse Brain in Stereotaxic Coordinates 2008, Academic Press, New York. 3rd ed.
12. Ge Y., Law M., Johnson G., Herbert J., Babb J.S., Mannon L.J., Grossman R.I. Preferential occult injury of corpus callosum in multiple sclerosis measured by diffusion tensor imaging. J. Magn. Reson. Imaging 2004, 20:1-7.
13. Gean-Marton A.D., Vezina L.G., Marton K.I., Stimac G.K., Peyster R.G., Taveras J.M., Davis K.R. Abnormal corpus callosum: a sensitive and specific indicator of multiple sclerosis. Radiology 1991, 180:215-221.
14. Groebe A., Clarner T., Baumgartner W., Dang J., Beyer C., Kipp M. Cuprizone treatment induces distinct demyelination, astrocytosis, and microglia cell invasion or proliferation in the mouse cerebellum. Cerebellum 2009, 8:163-174.
15. Gudi V., Moharregh-Khiabani D., Skripuletz T., Koutsoudaki P.N., Kotsiari A., Skuljec J., Trebst C., Stangel M. Regional differences between grey and white matter in cuprizone induced demyelination. Brain Res. 2009, 1283:127-138.
16. Hiremath M.M., Saito Y., Knapp G.W., Ting J.P., Suzuki K., Matsushima G.K. Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice. J. Neuroimmunol. 1998, 92:38-49.
17. Irvine K.A., Blakemore W.F. Remyelination protects axons from demyelination-associated axon degeneration. Brain 2008, 131:1464-1477.
18. Kipp M., Clarner T., Dang J., Copray S., Beyer C. The cuprizone animal model: new insights into an old story. Acta Neuropathol. 2009, 118:723-736.
19. Koutsoudaki P.N., Skripuletz T., Gudi V., Moharregh-Khiabani D., Hildebrandt H., Trebst C., Stangel M. Demyelination of the hippocampus is prominent in the cuprizone model. Neurosci. Lett. 2009, 451:83-88.
20. Linares D., Taconis M., Mana P., Correcha M., Fordham S., Staykova M., Willenborg D.O. Neuronal nitric oxide synthase plays a key role in CNS demyelination. J. Neurosci. 2006, 26:12672-12681.
21. Liu L., Belkadi A., Darnall L., Hu T., Drescher C., Cotleur A.C., Padovani-Claudio D., He T., Choi K., Lane T.E., Miller R.H., Ransohoff R.M. CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis. Nat. Neurosci. 2010, 13:319-326.
22. Lou X., Jiang W., Ma L., Ma N., Cai Y., Huang D., Wong E.H. Lower fractional anisotropy at the anterior body of the normal-appearing corpus callosum in multiple sclerosis versus symptomatic carotid occlusion. Neuroradiology 2009, 51:557-561.
23. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M., Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 2000, 47:707-717.
24. Ludwin S.K. Central nervous system demyelination and remyelination in the mouse: an ultrastructural study of cuprizone toxicity. Lab. Invest. 1978, 39:597-612.
25. Matsushima G.K., Morell P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 2001, 11:107-116.
26. Mi S., Miller R.H., Tang W., Lee X., Hu B., Wu W., Zhang Y., Shields C.B., Miklasz S., Shea D., Mason J., Franklin R.J., Ji B., Shao Z., Chedotal A., Bernard F., Roulois A., Xu J., Jung V., Pepinsky B. Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells. Ann. Neurol. 2009, 65:304-315.
27. Ozturk A., Smith S.A., Gordon-Lipkin E.M., Harrison D.M., Shiee N., Pham D.L., Caffo B.S., Calabresi P.A., Reich D.S. MRI of the corpus callosum in multiple sclerosis: association with disability. Mult. Scler. 2010, 16:166-177.
28. Pasquini L.A., Calatayud C.A., Bertone Una A.L., Millet V., Pasquini J.M., Soto E.F. The neurotoxic effect of cuprizone on oligodendrocytes depends on the presence of pro-inflammatory cytokines secreted by microglia. Neurochem. Res. 2007, 32:279-292.
29. Patel J.R., McCandless E.E., Dorsey D., Klein R.S. CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:11062-11067.
30. Plant S.R., Arnett H.A., Ting J.P. Astroglial-derived lymphotoxin-alpha exacerbates inflammation and demyelination, but not remyelination. Glia 2005, 49:1-14.
31. Poppenga R.H., Trapp A.L., Braselton W.E., Louden C.G., Gumbs J.M., Dalley J.B. Hexachlorophene toxicosis in a litter of Doberman pinschers. J. Vet. Diagn. Invest. 1990, 2:129-131.
32. Pott F., Gingele S., Clarner T., Dang J., Baumgartner W., Beyer C., Kipp M. Cuprizone effect on myelination, astrogliosis and microglia attraction in the mouse basal ganglia. Brain Res. 2009, 1305:137-149.
33. Raybaud C. The corpus callosum, the other great forebrain commissures, and the septum pellucidum: anatomy, development, and malformation. Neuroradiology 2010, 52:447-477.
34. Skripuletz T., Bussmann J.H., Gudi V., Koutsoudaki P.N., Pul R., Moharregh-Khiabani D., Lindner M., Stangel M. Cerebellar cortical demyelination in the murine cuprizone model. Brain Pathol. 2010, 20:301-312.
35. Skripuletz T., Lindner M., Kotsiari A., Garde N., Fokuhl J., Linsmeier F., Trebst C., Stangel M. Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent. Am. J. Pathol. 2008, 172:1053-1061.
36. Smith A.B., Smirniotopoulos J.G. Imaging evaluation of demyelinating processes of the central nervous system. Postgrad. Med. J. 2010, 86:218-229.
37. Stidworthy M.F., Genoud S., Suter U., Mantei N., Franklin R.J. Quantifying the early stages of remyelination following cuprizone-induced demyelination. Brain Pathol. 2003, 13:329-339.
38. Suzuki K., Kikkawa Y. Status spongiosus of CNS and hepatic changes induced by cuprizone (biscyclohexanone oxalyldihydrazone). Am. J. Pathol. 1969, 54:307-325.
39. Taylor L.C., Gilmore W., Matsushima G.K. SJL mice exposed to cuprizone intoxication reveal strain and gender pattern differences in demyelination. Brain Pathol. 2009, 19:467-479.
40. Taylor L.C., Gilmore W., Ting J.P., Matsushima G.K. Cuprizone induces similar demyelination in male and female C57BL/6 mice and results in disruption of the estrous cycle. J. Neurosci. Res. 2010, 88:391-402.
41. Tobin J.E., Xie M., Le T.Q., Song S.-K., Armstrong R.C. Reduced axonopathy and enhanced remyelination after chronic demyelination in fibroblast growth factor 2 (Fgf2)-null mice: differential detection with diffusion tensor imaging. J. Neuropathol. Exp. Neurol. 2011, 70:157-165. (110.1097/NEN.1090b1013e31820937e31820934).
42. Williams A., Piaton G., Lubetzki C. Astrocytes-friends or foes in multiple sclerosis?. Glia 2007, 55:1300-1312.
43. Wu Q.Z., Yang Q., Cate H.S., Kemper D., Binder M., Wang H.X., Fang K., Quick M.J., Marriott M., Kilpatrick T.J., Egan G.F. MRI identification of the rostral-caudal pattern of pathology within the corpus callosum in the cuprizone mouse model. J. Magn. Reson. Imaging 2008, 27:446-453.
44. Xie M., Tobin J.E., Budde M.D., Chen C.I., Trinkaus K., Cross A.H., McDaniel D.P., Song S.K., Armstrong R.C. Rostrocaudal analysis of corpus callosum demyelination and axon damage across disease stages refines diffusion tensor imaging correlations with pathological features. J. Neuropathol. Exp. Neurol. 2010, 69:704-716.
45. Yang H.J., Wang H., Zhang Y., Xiao L., Clough R.W., Browning R., Li X.M., Xu H. Region-specific susceptibilities to cuprizone-induced lesions in the mouse forebrain: implications for the pathophysiology of schizophrenia. Brain Res. 2009, 1270:121-130.